HEMO CHINA at CSA and TISC 2021
July 10, 2021
HEMO CHINA was present at CSA & TISC 2021, this year’s edition of the Annual Scientific Session of Chinese Stroke Association (CSA) and Tiantan International
Innovative interventional solutions addressing neurovascular and peripheral diseases
We have built a suite of innovative interventional medical devices targeting neuro-vascular diseases in China and the broader Asia-Pacific region. Our comprehensive portfolio of neuro-interventional medical devices covers the ischemic stroke, hemorrhagic stroke and neuro access fields.
Other than being a top notch neuro medical device manufacturer with EN ISO 13485, Certified Class 10K Cleanroom, we also provide the following services:
- OEM for medical devices
- Regulatory and Market Access partnership service for APAC Markets for medical device for China companies desiring to go international or overseas companies desiring to enter China
Contact us at enquire@hemocorp.com for our services.
Our Company's Devices
Mechanical Thrombectomy Devices
Our Company's Mechanical Thrombectomy Devices offers neuro-interventionalists in a differentiated tool for the treatment of acute ischemic stroke.
Our Mechanical Thrombectomy Devices consist of Aspiration Catheter and stent retriever system.
Click here to find out more.
Our Mechanical Thrombectomy Devices consist of Aspiration Catheter and stent retriever system.
Click here to find out more.
Access Devices
Our Company's Access Devices provides access for other neuro interventional devices in the treatment of acute ischemic stroke, intracranial atherosclerosis and hemorrhagic stroke
.
Our Access Devices consist of Intermediate Catheter, Balloon Guiding Catheter, and Micro Catheter.
Click here to find out more.
Our Access Devices consist of Intermediate Catheter, Balloon Guiding Catheter, and Micro Catheter.
Click here to find out more.
Dilation Devices
Our Company's Dilation Device offers neuro-interventionalists in a differentiated tool for the treatment of intracranial stenosis.
Our Dilation Device Consist of Balloon Dilation Catheter and Neuro Dilation Catheter(OTW).
Click here to find out more.
Our Dilation Device Consist of Balloon Dilation Catheter and Neuro Dilation Catheter(OTW).
Click here to find out more.
Resources
Interventional Treatment for Ischemic Stroke: A Game-Changer in Patient Outcomes
Ischemic stroke is a leading cause of disability and death worldwide, characterized by the sudden loss of blood flow to a part of the brain due to a clot obstructing a blood vessel. Traditional treatments have focused on clot-dissolving medications, but these are time-sensitive and not always effective. Recent advancements in interventional treatment, particularly mechanical thrombectomy, have revolutionized the management of ischemic stroke, offering new hope to patients who might otherwise face severe disability or death.
Click here to find out more.
Click here to find out more.
Recognizing Stroke Symptoms and Immediate Actions to Take Introduction
Strokes are a leading cause of death and disability worldwide. As such, recognize stroke symptoms early and acting quickly can save lives and significantly reduce the impact of a stroke. This article aims to educate the public on how to identify stroke symptoms and the immediate actions that should be taken.
Click here to find out more.
Click here to find out more.
Understanding the Differences Between Ischemic and Hemorrhagic Strokes
Strokes rank among the top causes of disability and death globally, highlighting the importance of understanding stroke types and their impact on the brain. The two main types, ischemic stroke and hemorrhagic stroke, differ in causes, symptoms, and treatment approaches. This article compares ischemic and hemorrhagic strokes to help you recognize stroke symptoms and the need for immediate medical intervention.
Click here to find out more.
Click here to find out more.
Our Latest News
HEMO Receives NMPA Approval for Afentta™ Aspiration Catheter
May 24, 2021
HEMO BIOENGINEERING LIMITED (“HEMO”), a Singapore-based medical device company with a focus on treating stroke patients, is pleased to announce that its Afentta™ intracranial thrombectomy
HEMO CHINA Recognised as 18th Top Medical Device Company in Future Medical VB100 List
April 19, 2021
Big congratulations go to our HEMO CHINA subsidiary for being recognized as the 18th Top Medical Device Company in this year’s prestigious Future Healthcare VB100
